Mankind Pharma IPO: What GMP signals ahead of listing on Tuesday

May 8, 2023

Mankind Pharma is set to list on May 9 with a premium of Rs 120 apiece according to grey market trends. The company is valued at a price-to-earnings ratio of 30 times FY22 earnings and has a market capitalisation of Rs 44,000 crore. The initial share sale of the company was subscribed 15.32 times with strong interest from QIBs and is the largest IPO so far this year. The company has 25 manufacturing facilities across India, a dedicated in-house R&D centre and a team of over 600 scientists.

More To Explore

A break above 18600 could take Nifty to fresh highs: Kunal Shah

Analysts anticipate that bulls will regain control in the Indian equity markets once the Nifty index breaks above 18,600 on a closing basis. The breakthrough

June 3, 2023

132 BSE500 stocks hit 52-week highs in May. Do you own any?

The positive momentum in the country’s markets helped their case. Some big names on the list include IndusInd Bank, Hindustan Aeronautics, Titan, Ultratech, Kotak Mahindra

June 3, 2023

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information.

Generated by Feedzy